Back

Impact of cardiovascular comorbidity burden in pulmonary arterial hypertension: a propensity score-matched analysis

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Risk assessment in pulmonary arterial hypertension Diagnostic Methods ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Qi Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

6 More presentations in this session

Presentation thumbnail
A modified 4-strata risk assessment incorporating TAPSE/sPAP for pulmonary arterial hypertension: evidence from a large chinese real-world cohort
Doctor S. Li (Beijing, CN)
Abstract
Presentation thumbnail
Discordance between PAH risk scores in systemic sclerosis–associated pulmonary arterial hypertension
Doctor A. Cruz Utrilla (Madrid, ES)
Abstract
Presentation thumbnail
Patient-reported physical activity improves risk stratification beyond COMPERA 2.0 in PAH and CTEPH
Mrs I. Silfversparre (Gothenburg, SE)
Abstract
Presentation thumbnail
Age as an independent predictor of mortality in idiopathic and connective tissue disease-associated PAH: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
Doctor A. Cruz Utrilla (Madrid, ES)
Abstract
Presentation thumbnail
Multidisciplinary, imaging-guided Potts shunt in pulmonary hypertension: timing and risk assessment
Doctor Z. Xu (Shanghai, CN)
Abstract

Access the full session

Session thumbnail
Risk assessment in pulmonary arterial hypertension

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities
3 September 2019
thumbnail
Congress Presentation
Comorbidity burden assessed by the Charlson comorbidity index and its influence on prognosis of patients admitted due to heart failure
21 March 2026
thumbnail
Congress Presentation
Prognostic value of pretest probability of heart failure with preserved ejection fraction in patients with coronary artery disease
29 August 2025
thumbnail
Congress Presentation
Reduction of cardiovascular events in patients with cardiovascular disease with the CV-polypill: a retrospective and propensity score matching study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources